P. Lefebvre

M. Picot, D. Nocca, D. Mariano-Goulart, 2019, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

The effect of excessive fat tissue on the measure of bone mineral density by dual X‐ray absorptiometry: the impact of substantial weight loss following sleeve gastrectomy

M. Picot, D. Nocca, V. Boudousq, 2019, Clinical physiology and functional imaging.

Real-world impact of glycated hemoglobin reduction on treatment intensification and glycated hemoglobin goal attainment in type 2 diabetes mellitus patients initiated on a sodium glucose co-transporter 2 (SGLT2) inhibitor (SGLT2i)

S. Brunton, P. Lefebvre, B. Bookhart, 2019, Current medical research and opinion.

Renal Denervation for Resistant Hypertension

M. Mcgregor, N. Dendukuri, P. Lefebvre, 2013 .

Incidence of Major Atherothrombotic Vascular Events among Patients with Peripheral Artery Disease after Revascularization.

W. Hiatt, C. Hess, D. Milentijevic, 2021, Annals of vascular surgery.

Economic outcomes with prasugrel versus clopidogrel in acute coronary syndrome patients: observations from prasugrel users and matched clopidogrel users

W. Olson, J. Schein, S. Lynch, 2015, Journal of medical economics.

Healthcare costs of NVAF patients treated with rivaroxaban and apixaban in the US

D. Milentijevic, P. Lefebvre, F. Laliberté, 2020, Journal of medical economics.

Cost-effectiveness of rivaroxaban compared with enoxaparin plus a vitamin K antagonist for the treatment of venous thromboembolism

S. Mody, C. Coleman, P. Lefebvre, 2014, Journal of medical economics.

Impact of limiting erythropoiesis‐stimulating agent use for chemotherapy‐induced anemia on the United States blood supply margin

C. Piech, F. Vekeman, M. Duh, 2009, Transfusion.

Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis

P. Mavros, P. Thompson-Leduc, P. Lefebvre, 2021, CNS Drugs.

Treatment Sequences and Pharmacy Costs of 2 New Therapies for Metastatic Castration-Resistant Prostate Cancer.

P. Lefebvre, D. Pilon, M. Lafeuille, 2015, American health & drug benefits.

An investigation into the durability of glycemic control in patients with type II diabetes initiated on canagliflozin or sitagliptin: A real-world analysis of electronic medical records.

C. Wysham, M. Duh, M. Ingham, 2019, Journal of diabetes and its complications.

Erythropoiesis-stimulating agents in the treatment of anemia in myelodysplastic syndromes: a meta-analysis

B. Yektashenas, M. Duh, P. Lefebvre, 2008, Annals of Hematology.

Risks and cost burden of venous thromboembolism and bleeding for patients undergoing total hip or knee replacement in a managed-care population

W. Olson, J. Schein, F. Vekeman, 2011, Journal of medical economics.

Risk of hepatotoxicity-related hospitalizations among patients treated with opioid/acetaminophen combination prescription pain medications.

P. Greenberg, E. Michna, F. Vekeman, 2010, Pain medicine.

Healthcare costs associated with nephrology care in pre-dialysis chronic kidney disease patients

C. Piech, R. Bailey, F. Vekeman, 2010, Journal of medical economics.

Drug utilization and cost for erythropoiesis-stimulating agents in a long-term care resident population with chronic kidney disease.

C. Piech, R. Bailey, F. Vekeman, 2010, The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists.

The economic impact of epoetin alfa therapy on delaying time to dialysis in elderly patients with chronic kidney disease.

C. Piech, S. Mody, M. Duh, 2007, Disease management : DM.

Dosing Patterns and Treatment Costs of Erythropoietic Agents in Elderly Patients with Pre-Dialysis Chronic Kidney Disease in Managed Care Organisations

C. Piech, S. Mody, M. Duh, 2006, Drugs & aging.

Dose and cost comparison of erythropoietic agents in the inpatient hospital setting.

C. Piech, S. Mody, F. Vekeman, 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities.

T. S. Chee, D. S. Kim, S. H. Lee, 2021, European journal of preventive cardiology.

Impact of Untreated Anemia on Hospitalization Rates in Patients With Diabetes and Chronic Kidney Disease

S. Mody, M. Duh, P. Lefebvre, 2007 .

Perspectives on the Common Drug Review Process at the Canadian Agency for Drugs and Technologies in Health

P. Lefebvre, M. Lafeuille, Sean Tiggelaar, 2017 .

Effectiveness, safety, and healthcare costs associated with rivaroxaban versus warfarin among venous thromboembolism patients with obesity: a real-world study in the United States

J. Berger, P. Lefebvre, F. Laliberté, 2022, Journal of Thrombosis and Thrombolysis.

Real-world effectiveness and safety of rivaroxaban versus warfarin among non-valvular atrial fibrillation patients with obesity in a US population

J. Berger, P. Lefebvre, F. Laliberté, 2021, Current medical research and opinion.

Real-World Analysis of Weight Gain and Body Mass Index Increase Among Patients with HIV-1 Using Antiretroviral Regimen Containing Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, or Neither in the United States

P. Lefebvre, M. Lafeuille, C. Rossi, 2022, Journal of health economics and outcomes research.

Development and validation of a claims-based model to identify patients at risk of chronic thromboembolic pulmonary hypertension following acute pulmonary embolism

R. Benza, A. Manceur, M. Kanwar, 2021, Current medical research and opinion.

Healthcare resource utilization and costs of major atherothrombotic vascular events among patients with peripheral artery disease after revascularization

Marc P. Bonaca, W. Hiatt, D. Milentijevic, 2021, Journal of medical economics.

Treatment Patterns and Predictors of Adherence in HIV Patients Receiving Single- or Multiple-Tablet Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide

P. Lefebvre, H. Hardy, M. Lafeuille, 2020, Patient preference and adherence.

Healthcare resource utilization and costs associated with inflammatory bowel disease among patients with chronic inflammatory diseases: a retrospective cohort study

J. Scher, S. Chakravarty, D. Hudesman, 2020, BMC Rheumatology.

Real-world outcomes post-transition to once-every-3-months paliperidone palmitate in patients with schizophrenia within US commercial plans

P. Lefebvre, N. Tandon, K. Joshi, 2019, Current medical research and opinion.

Are Medicaid Coverage Gaps Associated with Higher Health Care Resource Utilization and Costs in Patients with Schizophrenia?

J. Doshi, A. Manceur, P. Lefebvre, 2020, Population health management.

Real-World Prostate-Specific Antigen Response and Treatment Adherence of Apalutamide in Patients with Non-Metastatic Castration-Resistant Prostate Cancer.

N. Shore, P. Lefebvre, P. Sieber, 2022, Urology.

Medication Adherence, Treatment Patterns, and Dose Reduction in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone Acetate or Enzalutamide.

Yongling Xiao, P. Lefebvre, D. Pilon, 2017, American health & drug benefits.

Generic antiepileptic drugs and associated medical resource utilization in the United States

S. Helmers, D. Labiner, R. Manjunath, 2010, Neurology.

Economic burden associated with the use of generic antiepileptic drugs in the United States

S. Helmers, D. Labiner, R. Manjunath, 2010, Epilepsy & Behavior.

The Economic Burden of Posttraumatic Stress Disorder in the United States From a Societal Perspective.

L. Davis, P. Lefebvre, A. Guérin, 2022, The Journal of clinical psychiatry.

The effect of monophasic and triphasic oral contraceptives containing gestodene and desogestrel on body weight and composition

J. Bringer, P. Lefebvre, B. Hédon, 1996 .

The quantitative ultrasound method for assessing low bone mass in women with anorexia nervosa

P. Courtet, E. Renard, M. Picot, 2021, Archives of Osteoporosis.

Health‐care Cost Impact of Continued Anticoagulation With Rivaroxaban vs Aspirin for Prevention of Recurrent Symptomatic VTE in the EINSTEIN‐CHOICE Trial Population

M. Prins, Yongling Xiao, P. Prandoni, 2018, Chest.

Real-world use of omalizumab in patients with chronic idiopathic/spontaneous urticaria in the United States.

J. Bernstein, P. Lefebvre, B. Ortiz, 2018, Allergy and asthma proceedings.

In patients with anorexia nervosa, myokine levels are altered but are not associated with bone mineral density loss and bone turnover alteration

P. Courtet, E. Renard, M. Picot, 2022, Endocrine connections.

Out‐of‐pocket medical costs and third‐party healthcare costs for children with Down syndrome

B. Skotko, M. Duh, P. Lefebvre, 2017, American journal of medical genetics. Part A.

Income Growth Trajectory for Parents of Children with Down Syndrome in the United States

J. Campbell, B. Skotko, P. Lefebvre, 2016 .

Assessment of Evidence‐Based Standards in the Treatment of Advanced Prostate Cancer in a Community Practice

P. Lefebvre, D. Pilon, F. Gaylis, 2017, Urology practice.

Predictors of high healthcare resource utilization and liver disease progression among patients with chronic hepatitis C

P. Lefebvre, F. Laliberté, J. LaMori, 2015, Journal of medical economics.

Comparative Effectiveness Research: A Pharmaceutical Industry Perspective on Outlook, Dilemmas, and Controversies

C. Piech, P. Lefebvre, C. Pike, 2017 .

Costs associated with intravenous chemotherapy administration in patients with small cell lung cancer: a retrospective claims database analysis*

M. Neary, P. Lefebvre, A. Skarin, 2008 .

Influences of weight, body fat patterning and nutrition on the management of PCOS.

E. Renard, J. Bringer, P. Lefebvre, 1997, Human reproduction.

Medication patterns of abiraterone acetate plus prednisone or enzalutamide and PSA progression in veterans with metastatic castration-resistant prostate cancer

S. Freedland, Y. Young-Xu, P. Lefebvre, 2021, Current medical research and opinion.

Drug utilisation and cost considerations of erythropoiesis stimulating agents in oncology patients receiving chemotherapy: observations from a large managed-care database

F. Vekeman, M. Duh, P. Lefebvre, 2009, Journal of medical economics.

Cost burden and treatment patterns associated with management of heavy menstrual bleeding.

M. Duh, J. Jensen, P. Lefebvre, 2012, Journal of women's health.

Adherence Patterns for Abiraterone Acetate and Concomitant Prednisone Use in Patients with Prostate Cancer

C. Kozma, P. Lefebvre, M. Lafeuille, 2014, Journal of managed care & specialty pharmacy.

Body Composition and Regional Fat Distribution in Polycystic Ovarian Syndrome Relationship to Hormonal and Metabolic Profiles

E. Renard, J. Bringer, F. Grigorescu, 1993, Annals of the New York Academy of Sciences.

Cost per median overall survival month associated with abiraterone acetate and enzalutamide for treatment of patients with metastatic castration-resistant prostate cancer

P. Lefebvre, D. Pilon, L. Ellis, 2016, Journal of medical economics.

Real-world glycemic, blood pressure, and weight control in patients with type 2 diabetes mellitus treated with canagliflozin—an electronic health-record-based study

M. Duh, P. Lefebvre, M. Pfeifer, 2016, Current medical research and opinion.

Description of Baseline Characteristics of Pediatric Allergic Asthma Patients Including those Initiated on Omalizumab

P. Lefebvre, B. Ortiz, B. Paknis, 2018, Allergy & rhinology.

Récents progrès dans " l'hypothèse fibrinogène " Recent progress in " the fibrinogen hypothesis "

P. Lefebvre, J. Ducobu, 2003 .

Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy

M. Duh, P. Lefebvre, F. Laliberté, 2018, Menopause.

The economic burden of psoriasis with high comorbidity among privately insured patients in the United States

M. Ladouceur, E. Muser, P. Lefebvre, 2019, Journal of medical economics.

Development and evaluation of a predictive algorithm for unsatisfactory response among patients with pulmonary arterial hypertension using health insurance claims data

Jimmy Royer, P. Lefebvre, S. Panjabi, 2021, Current medical research and opinion.

Daratumumab Improves Depth of Response and Progression-free Survival in Transplant-ineligible, High-risk, Newly Diagnosed Multiple Myeloma

A. Jakubowiak, Shaji K. Kumar, P. Mavros, 2022, The oncologist.

Treatment patterns and effectiveness of patients with multiple myeloma initiating Daratumumab across different lines of therapy: a real-world chart review study

P. Thompson-Leduc, P. Lefebvre, S. Atrash, 2021, BMC Cancer.

Dose-Response Relationship Between Long-Term Systemic Corticosteroid Use and Related Complications in Patients with Severe Asthma.

Anand A. Dalal, H. Ortega, F. Albers, 2016, Journal of managed care & specialty pharmacy.

Costs of hospital visits among patients with deep vein thrombosis treated with rivaroxaban and LMWH/warfarin

J. Hollander, G. Merli, C. Pollack, 2016, Journal of medical economics.

Weekly risk of venous thromboembolism recurrence in patients receiving oral anticoagulants

C. Coleman, S. Kaatz, P. Lefebvre, 2014, Current medical research and opinion.

An assessment of erythroid response to epoetin α as a single agent versus in combination with granulocyte– or granulocyte‐macrophage–colony‐stimulating factor in myelodysplastic syndromes using a meta‐analysis approach

F. Vekeman, P. Lefebvre, V. Moyo, 2009, Cancer.

A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy

M. Duh, P. Lefebvre, Devi Sundaresan, 2017, International journal of chronic obstructive pulmonary disease.

Daily hospitalization costs in patients with deep vein thrombosis or pulmonary embolism treated with anticoagulant therapy.

S. Mody, J. Dasta, P. Lefebvre, 2015, Thrombosis research.

All-cause and disease-related health care costs associated with recurrent venous thromboembolism

W. Olson, J. Schein, S. Kaatz, 2013, Thrombosis and Haemostasis.

Matching-Adjusted Indirect Comparison of Health-Related Quality of Life and Adverse Events of Apalutamide Versus Enzalutamide in Non-Metastatic Castration-Resistant Prostate Cancer

B. Hadaschik, S. Oudard, S. Chowdhury, 2019, Advances in Therapy.

Healthcare Cost Impact of Continued Anticoagulation with Rivaroxaban versus Aspirin for Prevention of Recurrent Symptomatic Venous Thromboembolism in the EINSTEIN-CHOICE Trial Population Continued Anticoagulation with Rivaroxaban for Prevention of Recurrent Symptomatic Venous Thromboembolism in

M. Prins, Yongling Xiao, P. Prandoni, 2018 .

In-hospital risk of venous thromboembolism and bleeding and associated costs for patients undergoing total hip or knee arthroplasty

W. Olson, F. Vekeman, M. Duh, 2012, Journal of medical economics.

Abstract 15539: Anticoagulant Treatment Patterns for Cancer-Associated Thrombosis in a Commercial Insurance Population

A. Khorana, J. Schein, K. McCrae, 2017 .

Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure

C. McHorney, W. Nelson, J. Schein, 2015, Current medical research and opinion.

Cost comparison of continued anticoagulation with rivaroxaban versus placebo based on the 1-year EINSTEIN-Extension trial efficacy and safety results

Yongling Xiao, J. Schein, P. Wells, 2018, Journal of medical economics.

Understanding the Health System Conditions Affecting the Use of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia in Clinical Practice: A US Healthcare Provider Survey

P. Lefebvre, D. Pilon, M. Zhdanava, 2022, Neuropsychiatric disease and treatment.

Medication adherence, healthcare resource utilization, and costs among Medicaid beneficiaries with schizophrenia treated with once-monthly paliperidone palmitate or once-every-three-months paliperidone palmitate

P. Lefebvre, D. Lin, K. Joshi, 2021, Current medical research and opinion.

Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical Antipsychotics.

P. Lefebvre, N. Tandon, K. Joshi, 2017, Clinical therapeutics.

Treatment patterns in Medicaid patients with schizophrenia initiated on a first- or second-generation long-acting injectable versus oral antipsychotic

P. Lefebvre, N. Tandon, K. Joshi, 2017, Patient preference and adherence.

Treatment Patterns, Healthcare Resource Utilization, and Spending Among Medicaid-Enrolled Children with Chronic Idiopathic/Spontaneous Urticaria in the United States

Yongling Xiao, Paul V. Williams, V. Hernandez-Trujillo, 2018, Dermatology and Therapy.

Is Serum Serotonin Involved in the Bone Loss of Young Females with Anorexia Nervosa?

P. Courtet, E. Renard, M. Picot, 2015, Hormone and Metabolic Research.

Role of sclerostin and dickkopf-1 in the dramatic alteration in bone mass acquisition in adolescents and young women with recent anorexia nervosa.

P. Courtet, E. Renard, J. Bringer, 2014, The Journal of clinical endocrinology and metabolism.

Effect Of Prasugrel Vs Clopidogrel On Hospital Readmission Among Acute Coronary Syndrome Patients Treated With Prasugrel

W. Olson, J. Schein, S. Lynch, 2014 .

Treatment persistence and hospitalization rates among patients with schizophrenia: a quasi-experiment to evaluate a patient information program

P. Lefebvre, C. Benson, D. Pilon, 2017, Current medical research and opinion.

Definition of an adapted cut-off for determining low lean tissue mass in older women with obesity: a comparison to current cut-offs

E. Renard, A. Avignon, D. Nocca, 2022, Scientific Reports.

CMS hospital readmission reduction program and anticoagulants received following a total hip and knee arthroplasty discharge

Yongling Xiao, J. Schein, C. Coleman, 2018, Current medical research and opinion.

Persistence to hypomethylating agents and clinical and economic outcomes among patients with myelodysplastic syndromes

P. Lefebvre, F. Laliberté, W. Cheng, 2021, Hematology.

Real-World Persistence and Time to Next Treatment With Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Including Patients at High Risk for Atrial Fibrillation or Stroke.

Shaun P. Forbes, A. Narezkina, P. Lefebvre, 2021, Clinical lymphoma, myeloma & leukemia.

Cancer associated thrombosis and mortality in patients with cancer stratified by khorana score risk levels

A. Khorana, G. Lyman, K. McCrae, 2020, Cancer medicine.

Healthcare resource utilization and costs associated with venous thromboembolism recurrence in patients with cancer

A. Khorana, K. McCrae, D. Milentijevic, 2016, Journal of medical economics.

Excess healthcare resource utilization and healthcare costs among privately and publicly insured patients with major depressive disorder and acute suicidal ideation or behavior in the United States.

L. Citrome, J. Sheehan, P. Lefebvre, 2022, Journal of affective disorders.

Economic Burden of Commercially Insured Patients With Major Depressive Disorder and Acute Suicidal Ideation or Behavior in the United States.

P. Greenberg, J. Sheehan, C. Neslusan, 2022, The Journal of clinical psychiatry.

Treatment patterns among adults with attention-deficit/hyperactivity disorder in the United States: a retrospective claims study

J. Schein, P. Lefebvre, A. Guérin, 2021, Current medical research and opinion.

Patient characteristics, treatment patterns, and outcomes among black and white patients with multiple myeloma mnitiating daratumumab: A real-world chart review study.

P. Thompson-Leduc, P. Lefebvre, S. Atrash, 2022, Clinical lymphoma, myeloma & leukemia.

Effectiveness, safety, and healthcare costs associated with rivaroxaban versus warfarin among venous thromboembolism patients with obesity: a real-world study in the United States

J. Berger, P. Lefebvre, F. Laliberté, 2022, Journal of Thrombosis and Thrombolysis.

Abstract 13611: Adherence to Non-VKA Oral Anticoagulant Medications Based on the Pharmacy Quality Alliance Measure

C. McHorney, W. Nelson, J. Schein, 2015 .

Abstract 366: Pharmacy Quality Alliance Measure: Adherence to Non-Warfarin Oral Anticoagulant Medication

W. Nelson, J. Schein, P. Lefebvre, 2015 .

Association between consistent omalizumab treatment and asthma control.

P. Lefebvre, Jie Zhang, M. Lafeuille, 2013, The journal of allergy and clinical immunology. In practice.

Associations between adverse childhood experiences and clinical characteristics of eating disorders

P. Courtet, I. Jaussent, E. Renard, 2016, Scientific Reports.

Impact of COVID-19 Pandemic on Prescribing of Long-Acting Injectable Antipsychotics for Schizophrenia: Results from a United States Prescriber Survey

P. Lefebvre, D. Pilon, M. Zhdanava, 2022, Neuropsychiatric disease and treatment.

NDT_A_379985 2003..2019

P. Lefebvre, D. Pilon, M. Zhdanava, 2022 .

Risk of subsequent relapses and corresponding healthcare costs among recently-relapsed Medicaid patients with schizophrenia: a real-world retrospective cohort study

Edward Kim, P. Lefebvre, D. Lin, 2021, Current medical research and opinion.

Neutrophils to Lymphocytes Ratio (NLR) Variation in Relationship with Childhood Maltreatment in Patients with Anorexia Nervosa: A Retrospective Cohort Study

P. Courtet, E. Renard, S. Guillaume, 2021 .

The impact of drug vintage on patient survival: a patient-level analysis using Quebec's provincial health plan data.

F. Lichtenberg, P. Grootendorst, P. Lefebvre, 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Real-world utilization and outcomes of systemic therapy among patients with advanced or recurrent endometrial cancer in the United States

P. Thaker, J. Hurteau, P. Lefebvre, 2022, Current medical research and opinion.

Economic Burden Associated With Nasal Polyposis Recurrence Among Commercially Insured Patients in the United States.

P. Lefebvre, J. Suh, D. Pilon, 2022, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Five-year results of laparoscopic sleeve gastrectomy for the treatment of severe obesity

D. Nocca, P. Lefebvre, M. Nedelcu, 2017, Surgical Endoscopy.

Treatment outcomes, health-care resource utilization and costs of bortezomib and dexamethasone, with cyclophosphamide or lenalidomide, in newly diagnosed multiple myeloma

A. Dispenzieri, M. Lacy, M. Duh, 2016, Leukemia.

Real-world evaluation of Hba1c, blood pressure, and weight loss among patients with type 2 diabetes mellitus treated with canagliflozin: an analysis of electronic medical records from a network of hospitals in Florida

D. Tanton, R. Bailey, M. Duh, 2018, Current medical research and opinion.

Quality measure attainment in patients with type 2 diabetes mellitus.

Lawrence D Garber, R. Bailey, P. Lefebvre, 2014, The American journal of managed care.

Meta-analysis of the efficacy and safety of bortezomib re-treatment in patients with multiple myeloma.

K. Knopf, M. Duh, R. Comenzo, 2014, Clinical lymphoma, myeloma & leukemia.

Incidence and economic burden of respiratory syncytial virus among adults in the United States: A retrospective analysis using 2 insurance claims databases.

L. Lamerato, P. Lefebvre, B. Bookhart, 2022, Journal of managed care & specialty pharmacy.

Clinical and cost burden of rotavirus infection before and after introduction of rotavirus vaccines among commercially and Medicaid insured children in the United States

G. Krishnarajah, P. Lefebvre, K. Demissie, 2014, Human vaccines & immunotherapeutics.

Clinical predictors of survival in men with castration‐resistant prostate cancer

P. Kantoff, M. Taplin, C. Sweeney, 2013, Cancer.

Cluster Analysis of Care Pathways in Adults with Major Depressive Disorder with Acute Suicidal Ideation or Behavior in the USA

C. Neslusan, P. Lefebvre, K. Joshi, 2021, PharmacoEconomics.

Healthcare resource utilization and costs associated with first-line ibrutinib compared to chemoimmunotherapy treatment among Medicare beneficiaries with chronic lymphocytic leukemia

A. Mato, M. Sundaram, P. Lefebvre, 2020, Current medical research and opinion.

The contribution of teledentistry in detecting tooth erosion in patients with eating disorders

N. Giraudeau, P. Lefebvre, C. Inquimbert, 2021, Digital health.

Risk of Treatment Discontinuation among Patients with Psoriasis Initiated on Ustekinumab and Other Biologics in the USA

T. Fitzgerald, P. Lefebvre, D. Pilon, 2022, Dermatology and Therapy.

Real-world incidence of inflammatory bowel disease among patients with other chronic inflammatory diseases treated with interleukin-17a or phosphodiesterase 4 inhibitors

M. Ladouceur, S. Chakravarty, P. Lefebvre, 2019, Current medical research and opinion.

Identification of two novel insulin receptor mutations, Asp59Gly and Leu62Pro, in type A syndrome of extreme insulin resistance.

C. Lautier, E. Renard, J. Brun, 1997, Biochemical and biophysical research communications.

Medicaid spending on contraceptive coverage and pregnancy-related care

P. Darney, M. Duh, P. Lefebvre, 2014, Reproductive Health.

Clinical and economic burden of tumor lysis syndrome among patients with chronic lymphocytic leukemia/small lymphocytic lymphoma: A real-world US retrospective study.

K. Rogers, P. Lefebvre, Xiaoxiao Lu, 2022, Journal of managed care & specialty pharmacy.

Cost Savings of Expedited Care with Upfront Next-Generation Sequencing Testing versus Single-Gene Testing among Patients with Metastatic Non-Small Cell Lung Cancer Based on Current Canadian Practices

E. Ewara, P. Lefebvre, P. Cheema, 2023, Current oncology.

Patient and Caregiver Burden Associated With Fragile X Syndrome in the United States.

F. Vekeman, M. Duh, P. Lefebvre, 2015, American journal on intellectual and developmental disabilities.

Health Care Resource Use and Direct Costs Associated with Fragile X Syndrome (FXS) in the United States

F. Vekeman, M. Duh, P. Lefebvre, 2013 .

Assessment of Real-World Central Nervous System Events in Patients with Advanced Prostate Cancer Using Abiraterone Acetate, Bicalutamide, Enzalutamide, or Chemotherapy.

N. Dawson, P. Lefebvre, M. Robitaille, 2017, American health & drug benefits.

The Impact of Retrospective Childhood Maltreatment on Eating Disorders as Mediated by Food Addiction: A Cross-Sectional Study

P. Courtet, E. Renard, S. Guillaume, 2020, Nutrients.

Duration of Treatment in Prostate Cancer Patients Treated with Abiraterone Acetate or Enzalutamide.

N. Dawson, P. Lefebvre, D. Pilon, 2017, Journal of managed care & specialty pharmacy.

MP52-11 ASSOCIATION OF DOSE REDUCTION OF ABIRATERONE ACETATE PLUS PREDNISONE OR ENZALUTAMIDE AND PSA PROGRESSION IN VETERANS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER

S. Freedland, Y. Young-Xu, A. Fuld, 2018 .

Total cost of testing for genomic alterations associated with next-generation sequencing versus polymerase chain reaction testing strategies among patients with metastatic non-small cell lung cancer

P. Lefebvre, M. Lafeuille, L. Morrison, 2022, Journal of medical economics.

Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: a cohort study

A. Shorr, M. Zilberberg, F. Vekeman, 2007, Critical care.

Initial Combination Therapy Reduces the Risk of Cardiovascular Events in Hypertensive Patients: A Matched Cohort Study

H. Parise, A. Gradman, M. Duh, 2013, Hypertension.

Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Non-valvular Atrial Fibrillation (NVAF) Patients with Diabetes in a US Population

J. Berger, M. Weir, P. Lefebvre, 2023, Advances in Therapy.

Healthcare resource utilization and costs of rivaroxaban versus warfarin among non-valvular atrial fibrillation (NVAF) patients with obesity in a US population

J. Berger, P. Lefebvre, F. Laliberté, 2021, Journal of medical economics.

Economic burden of rivaroxaban and warfarin among nonvalvular atrial fibrillation patients with obesity and polypharmacy.

J. Berger, P. Lefebvre, F. Laliberté, 2021, Journal of comparative effectiveness research.

Effects of rivaroxaban versus warfarin on hospitalization days and other health care resource utilization in patients with nonvalvular atrial fibrillation: an observational study from a cohort of matched users.

W. Olson, W. Nelson, J. Schein, 2015, Clinical therapeutics.

Is rivaroxaban associated with lower inpatient costs compared to warfarin among patients with non-valvular atrial fibrillation?

W. Olson, W. Nelson, J. Schein, 2014, Current medical research and opinion.

Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients

W. Olson, W. Nelson, J. Schein, 2014, Current medical research and opinion.

Pharmacy quality alliance measure: adherence to non-warfarin oral anticoagulant medications

W. Nelson, J. Schein, P. Lefebvre, 2015, Current medical research and opinion.

Risk factors associated with myocardial infarction in venous thromboembolism patients

S. Kaatz, P. Lefebvre, F. Laliberté, 2014, Current medical research and opinion.

Implications of stroke and bleeding risk scores and comorbidities on episode-based bundled payments for patients with nonvalvular atrial fibrillation

W. Nelson, J. Schein, C. Coleman, 2018, Current medical research and opinion.

Stroke risk reduction outweighed bleeding risk increase from vitamin K antagonist treatment among nonvalvular atrial fibrillation patients with high stroke risk and low bleeding risk

W. Nelson, P. Lefebvre, F. Laliberté, 2017, Current medical research and opinion.

Indicators of Suboptimal Treatment and Associated Healthcare Costs Among Patients With Crohn’s Disease Initiated on Biologic or Conventional Agents

A. Manceur, E. Muser, P. Lefebvre, 2022, Crohn's & Colitis 360.

Burden of Crohn’s disease in the United States: long-term healthcare and work-loss related costs

A. Manceur, E. Muser, P. Lefebvre, 2020, Journal of medical economics.

Long-term direct and indirect costs of ulcerative colitis in a privately-insured United States population

A. Manceur, E. Muser, P. Lefebvre, 2020, Current medical research and opinion.

Treatment patterns among patients with advanced/recurrent endometrial cancer in the United States.

P. Thaker, J. Hurteau, P. Lefebvre, 2021 .

Prevalence of post-traumatic stress disorder in the United States: a systematic literature review

L. Davis, P. Lefebvre, O. Patterson-Lomba, 2021, Current medical research and opinion.

Comparison of Time to Next Treatment, Health Care Resource Utilization, and Costs in Patients with Chronic Lymphocytic Leukemia Initiated on Front-line Ibrutinib or Chemoimmunotherapy

A. Mato, M. Sundaram, P. Lefebvre, 2019, Clinical lymphoma, myeloma & leukemia.

Real-world treatment sequencing and healthcare costs among CLL/SLL patients treated with venetoclax

A. Manceur, K. Rogers, P. Lefebvre, 2021, Current medical research and opinion.

Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data

A. Manceur, James B. Young, C. Wysham, 2018, Cardiovascular Diabetology.

Impact of atypical long-acting injectable versus oral antipsychotics on rehospitalization rates and emergency room visits among relapsed schizophrenia patients: a retrospective database analysis

J. Fastenau, M. Duh, P. Lefebvre, 2013, BMC Psychiatry.

Impact of bipolar disorder on eating disorders severity in real-life settings.

P. Courtet, I. Jaussent, E. Renard, 2019, Journal of affective disorders.

Pulse pressure and stroke risk: development and validation of a new stroke risk model

Patrick Lefebvre, F. Vekeman, R. Ayyagari, 2014, Current medical research and opinion.

Sa1567: PERSISTENCE AND ADHERENCE AMONG PATIENTS WITH ULCERATIVE COLITIS INITIATED ON USTEKINUMAB

A. Manceur, P. Lefebvre, S. Kachroo, 2022, Gastroenterology.

Comparable Outcomes With Bortezomib-Cyclophosphamide-Dexamethasone (VCD) and Bortezomib-Lenalidomide-Dexamethasone (VRD) For Initial Treatment Of Newly Diagnosed Multiple Myeloma (MM)

Ocn, A. Dispenzieri, S. Rajkumar, 2013 .

Economic burden of treatment failure in chronic lymphocytic leukemia patients

P. Lefebvre, M. Lafeuille, M. Senbetta, 2018, Current medical research and opinion.

Clinical benefits of once-weekly epoetin alfa in anemic patients with colorectal cancer receiving chemotherapy.

L. Einhorn, E. Chu, P. Lefebvre, 2006, The journal of supportive oncology.

Effects of Hormonal Contraception Use on Cognitive Functions in Patients With Bulimia Nervosa

I. Jaussent, E. Renard, S. Guillaume, 2021, Frontiers in Psychiatry.

Structural differences in eating disorder psychopathology after history of childhood abuse: Insights from a Bayesian network analysis.

P. Courtet, I. Jaussent, E. Renard, 2019, Journal of abnormal psychology.

Comparative Effectiveness and Safety of Rivaroxaban and Warfarin Among Nonvalvular Atrial Fibrillation (NVAF) Patients with Obesity and Polypharmacy in the United States (US)

J. Berger, P. Lefebvre, F. Laliberté, 2021, Advances in Therapy.

Treatment persistence among bio-naïve patients with Crohn’s disease initiated on ustekinumab or adalimumab

A. Manceur, E. Muser, P. Lefebvre, 2023, Current medical research and opinion.

The Prevalence and National Burden of Treatment-Resistant Depression and Major Depressive Disorder in the United States.

J. Sheehan, P. Lefebvre, K. Joshi, 2021, The Journal of clinical psychiatry.

Gastrointestinal comorbidities associated with atrial fibrillation

S. Mody, J. Schein, P. Lefebvre, 2014, SpringerPlus.

Risk of Ischemic Stroke in Patients Newly Diagnosed With Heart Failure: Focus on Patients Without Atrial Fibrillation.

E. Peterson, J. Schein, J. Berger, 2018, Journal of cardiac failure.

Acute and chronic systemic corticosteroid-related complications in patients with severe asthma.

Anand A. Dalal, H. Ortega, F. Albers, 2015, The Journal of allergy and clinical immunology.

All-Cause and Potentially Disease-Related Health Care Costs Associated with Venous Thromboembolism in Commercial, Medicare, and Medicaid Beneficiaries

W. Olson, J. Schein, S. Kaatz, 2012, Journal of managed care pharmacy : JMCP.

Medical costs of untreated anemia in elderly patients with predialysis chronic kidney disease.

S. Mody, S. Buteau, M. Duh, 2006, Journal of the American Society of Nephrology : JASN.

Economic simulation of canagliflozin and sitagliptin treatment outcomes in patients with type 2 diabetes mellitus with inadequate glycemic control

Lawrence D Garber, R. Bailey, M. Duh, 2015, Journal of medical economics.

Relationship between patient copayments in Medicare Part D and vaccination claim status for herpes zoster and tetanus-diphtheria-acellular pertussis

Songkai Yan, G. Krishnarajah, M. Duh, 2018, Current medical research and opinion.

Health care resource use, short-term disability days, and costs associated with states of persistence on antidepressant lines of therapy

L. Citrome, J. Sheehan, P. Lefebvre, 2021, Journal of medical economics.

Venous thromboembolism and cardiovascular disease complications in menopausal women using transdermal versus oral estrogen therapy

J. Simon, J. Nyirady, M. Duh, 2016, Menopause.

Costs Associated with Intravenous Cancer Therapy Administration in Patients with Metastatic Soft Tissue Sarcoma in a US Population

L. Miller, M. Duh, P. Lefebvre, 2013, Sarcoma.

Clinical outcomes of prolonged anticoagulation with rivaroxaban after unprovoked venous thromboembolism

Yongling Xiao, J. Schein, J. Berger, 2017, Research and practice in thrombosis and haemostasis.

Risk for Venous Thromboembolism Recurrence Among Rivaroxaban-treated Patients Who Continued Versus Discontinued Therapy: Analyses Among Patients with VTE.

A. Khorana, J. Schein, J. Berger, 2017, Clinical Therapeutics.

Economic Burden and Health-Related Quality of Life Associated with Current Treatments for Anaemia in Patients with CKD not on Dialysis: A Systematic Review

W. Winkelmayer, H. Krasa, R. Pecoits-Filho, 2019, PharmacoEconomics - open.

Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa

P. Cremieux, F. Vekeman, C. Enny, 2006, Current medical research and opinion.

The societal economic value of COVID-19 vaccines in the United States

E. Swallow, P. Lefebvre, B. Bookhart, 2022, Journal of medical economics.

The triglycerides and glucose (TyG) index: a new marker associated with nonalcoholic steatohepatitis (NASH) in obese patients.

E. Renard, M. Picot, F. Galtier, 2022, Diabetes & metabolism.

Adherence to heart failure management medications following cardiac resynchronization therapy

Yongling Xiao, B. Shah, J. Dasta, 2020, Current medical research and opinion.

Dosing patterns and costs of erythropoietic agents in patients with chronic kidney disease not on dialysis in managed care organizations.

S. Mody, M. Duh, P. Lefebvre, 2006, Clinical therapeutics.

Quality goal attainment and maintenance in patients with type II diabetes mellitus initiated on canagliflozin or a glucagon-like peptide-1 receptor agonist in an actual practice setting

C. Wysham, M. Ingham, P. Lefebvre, 2018, Current medical research and opinion.

Economic modelling of costs associated with outcomes reported for type 2 diabetes mellitus (T2DM) patients in the CANVAS and EMPA-REG cardiovascular outcomes trials

A. Manceur, Jennifer Cai, P. Lefebvre, 2019, Journal of medical economics.

Nutrient deficiencies in patients with obesity considering bariatric surgery: a cross-sectional study.

F. Galtier, D. Nocca, A. Sultan, 2014, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

HBA1C CONTROL AND COST-EFFECTIVENESS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INITIATED ON CANAGLIFLOZIN OR A GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONIST IN A REAL-WORLD SETTING.

C. Wysham, M. Ingham, P. Lefebvre, 2018, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

The risk of recurrent VTE and major bleeding in a commercially‐insured population of cancer patients treated with anticoagulation

A. Khorana, J. Schein, K. McCrae, 2018, American journal of hematology.

Impact of Daily Dosing Frequency on Adherence to Chronic Medications Among Nonvalvular Atrial Fibrillation Patients

W. Nelson, J. Schein, M. Duh, 2012, Advances in Therapy.

Ejection fraction, B‐type natriuretic peptide and risk of stroke and acute myocardial infarction among patients with heart failure

E. Peterson, G. Fonarow, J. Berger, 2019, Clinical cardiology.

The relative dosing of epoetin alfa and darbepoetin alfa in chronic kidney disease

P. Cremieux, P. Lefebvre, M. V. Audenrode, 2006, Current medical research and opinion.

Retrospective analysis of the impact of increasing access to long acting reversible contraceptives in a commercially insured population

M. Duh, P. Lefebvre, F. Laliberté, 2016, Reproductive Health.

Anaemia and the Risk of Injurious Falls in a Community-Dwelling Elderly Population

S. Mody, S. Buteau, M. Duh, 2008, Drugs & aging.

Improvement in Quality of Life After Laparoscopic Sleeve Gastrectomy

E. Renard, J. Bringer, D. Nocca, 2011, Obesity surgery.

Burden of uncontrolled epilepsy in patients requiring an emergency room visit or hospitalization

H. Parise, E. Faught, R. Manjunath, 2012, Neurology.

Economic impact of generic substitution of lamotrigine: projected costs in the US using findings in a Canadian setting

J. LeLorier, R. Manjunath, P. Lefebvre, 2008 .

Economic impact of generic substitution of lamotrigine: projected costs in the US using findings in a Canadian setting.

J. LeLorier, R. Manjunath, M. Duh, 2008, Current medical research and opinion.

Increasing COVID-19 vaccination in the United States: projected impact on cases, hospitalizations, and deaths by age and racial group

E. Swallow, P. Lefebvre, Cirrus Foroughi, 2022, Public Health.

Management of Patients with Metastatic Castration-Sensitive Prostate Cancer in the Real-World Setting in the United States

S. Freedland, C. Ryan, P. Lefebvre, 2021, The Journal of urology.

Surgical glue in laparoscopic sleeve gastrectomy: An initial experience and cost‐effectiveness analysis

D. Nocca, G. Mercier, P. Lefebvre, 2017, Journal of evaluation in clinical practice.

Real-World Corticosteroid Utilization Patterns in Patients with Metastatic Castration-Resistant Prostate Cancer in 2 Large US Administrative Claims Databases.

P. Lefebvre, M. Lafeuille, R. McKenzie, 2013, American health & drug benefits.

Comparison of clinical outcomes in patients with schizophrenia following different long-acting injectable event-driven initiation strategies

C. Correll, P. Mavros, P. Lefebvre, 2023, Schizophrenia.

Real-World Racial Variation in Treatment and Outcomes Among Patients with Peripheral Artery Disease

K. Ferdinand, P. Lefebvre, F. Laliberté, 2023, Advances in Therapy.

Modeling the impact of real-world adherence to once-daily (QD) versus twice-daily (BID) non-vitamin K antagonist oral anticoagulants on stroke and major bleeding events among non-valvular atrial fibrillation patients

C. McHorney, E. Peterson, J. Schein, 2018, Current medical research and opinion.

Adherence to rivaroxaban versus apixaban among patients with non-valvular atrial fibrillation: Analysis of overall population and subgroups of prior oral anticoagulant users

C. McHorney, P. Lefebvre, F. Laliberté, 2018, PloS one.

Comparison of Adherence to Rivaroxaban Versus Apixaban Among Patients With Atrial Fibrillation.

C. McHorney, E. Peterson, W. Nelson, 2016, Clinical therapeutics.

Direct and indirect cost burden associated with multiple sclerosis relapses: Excess costs of persons with MS and their spouse caregivers

B. Weinstock-Guttman, H. Parise, M. Duh, 2013, Journal of the Neurological Sciences.

Impact of Once-Daily Versus Twice-Daily Dosing Frequency on Adherence to Chronic Medications among Patients with Venous Thromboembolism

W. Nelson, J. Schein, M. Duh, 2013, The Patient - Patient-Centered Outcomes Research.

Quality measure and weight loss assessment in patients with type 2 diabetes mellitus treated with canagliflozin or dipeptidyl peptidase-4 inhibitors

C. Wysham, M. Duh, M. Ingham, 2017, BMC Endocrine Disorders.

Role of allelic variants Gly972Arg of IRS-1 and Gly1057Asp of IRS-2 in moderate-to-severe insulin resistance of women with polycystic ovary syndrome.

C. Lautier, E. Renard, J. Gris, 2001, Diabetes.

Identification of patients with metastatic castration-sensitive or metastatic castration-resistant prostate cancer using administrative health claims and laboratory data

S. Freedland, C. Ryan, P. Lefebvre, 2021, Current medical research and opinion.

Effectiveness and safety of anticoagulants for the treatment of venous thromboembolism in patients with cancer

A. Khorana, W. Nelson, J. Schein, 2018, American journal of hematology.

Attainment of early, deep prostate-specific antigen response in metastatic castration-sensitive prostate cancer: A comparison of patients initiated on apalutamide or enzalutamide.

E. Muser, I. Khilfeh, P. Lefebvre, 2022, Urologic oncology.

Direct and Indirect Cost Burden and Change of Employment Status in Treatment-Resistant Depression: A Matched-Cohort Study Using a US Commercial Claims Database.

P. Greenberg, I. Pivneva, P. Lefebvre, 2018, The Journal of clinical psychiatry.

Development of risk models for major adverse chronic renal outcomes among patients with type 2 diabetes mellitus using insurance claims: a retrospective observational study

A. Manceur, James B. Young, C. Wysham, 2020, Current medical research and opinion.

Economic burden of treatment-resistant depression in privately insured US patients with co-occurring anxiety disorder and/or substance use disorder

P. Lefebvre, K. Joshi, D. Pilon, 2020, Current medical research and opinion.

Predictors of survival, healthcare resource utilization, and healthcare costs in veterans with non-metastatic castration-resistant prostate cancer.

S. Freedland, Y. Young-Xu, P. Lefebvre, 2020, Urologic oncology.

Ischemic Stroke and Systemic Embolism Among One-and-Done Direct Oral Anticoagulant Users with Non-valvular Atrial Fibrillation

M. Alberts, P. Lefebvre, B. Bookhart, 2023, Advances in therapy.

Comparison of prostate-specific antigen response in patients with metastatic castration-sensitive prostate cancer initiated on apalutamide or abiraterone acetate: A retrospective cohort study.

E. Muser, I. Khilfeh, P. Lefebvre, 2023, Urologic oncology.

Early prostate-specific antigen response among Black and non-Black patients with advanced prostate cancer treated with apalutamide.

I. Khilfeh, P. Lefebvre, D. Pilon, 2022, Future oncology.

Projected economic impact of clinical findings of generic entry of topiramate on G4 European countries

M. Duh, P. Lefebvre, P. E. Paradis, 2009, Current medical research and opinion.

Healthcare costs of patients with cancer stratified by Khorana score risk levels

A. Khorana, G. Lyman, K. McCrae, 2021, Journal of medical economics.

Long-term omalizumab outcomes in chronic idiopathic urticaria: A real-world study.

P. Lefebvre, B. Ortiz, J. Lecocq, 2019, Allergy and asthma proceedings.

Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab

T. Fitzgerald, R. Melsheimer, P. Lefebvre, 2021, Biologics : targets & therapy.

Impact of omalizumab on emergency-department visits, hospitalizations, and corticosteroid use among patients with uncontrolled asthma.

M. Duh, P. Lefebvre, Jie Zhang, 2012, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Health care burden and treatment patterns in commercially insured children with chronic idiopathic/spontaneous urticaria: A real-world study in the United States.

Paul D. Williams, Yongling Xiao, V. Hernandez-Trujillo, 2018, Allergy and asthma proceedings.

Impact of completing chronic hepatitis C (CHC) treatment on post-therapy healthcare cost

P. Lefebvre, F. Laliberté, N. Tandon, 2014, Journal of medical economics.

Real-World Analysis of Switching Patients with Schizophrenia from Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate

P. Lefebvre, N. Tandon, A. E. El Khoury, 2019, Drugs - Real World Outcomes.

Projecting the economic outcomes of switching patients with schizophrenia from oral atypical antipsychotics to once-monthly, once-every-3-months, and once-every-6-months paliperidone palmitate.

P. Lefebvre, C. Benson, D. Lin, 2022, Journal of Managed Care & Specialty Pharmacy.

National and regional description of healthcare measures among adult Medicaid beneficiaries with schizophrenia within the United States

P. Lefebvre, C. Benson, D. Gupta, 2022, Journal of medical economics.

Economic Impact in Medicaid Beneficiaries with Schizophrenia and Cardiometabolic Comorbidities Treated with Once-Monthly Paliperidone Palmitate vs. Oral Atypical Antipsychotics

Edward Kim, P. Lefebvre, N. Tandon, 2018, Drugs - Real World Outcomes.

Adherence, healthcare resource utilization and Medicaid spending associated with once-monthly paliperidone palmitate versus oral atypical antipsychotic treatment among adults recently diagnosed with schizophrenia

E. Muser, P. Lefebvre, K. Joshi, 2017, BMC Psychiatry.

Impact of Paliperidone Palmitate Versus Oral Atypical Antipsychotics on Health Care Resource Use and Costs in Veterans with Schizophrenia.

B. Shiner, Y. Young-Xu, E. Muser, 2016, The Journal of clinical psychiatry.

Factors Associated with Adherence to the HEDIS Quality Measure in Medicaid Patients with Schizophrenia.

J. Fastenau, M. Duh, P. Lefebvre, 2016, American health & drug benefits.

Systematic review of long-acting injectables versus oral atypical antipsychotics on hospitalization in schizophrenia

R. Dirani, J. Fastenau, M. Duh, 2014, Current medical research and opinion.

Burden of treatment-resistant depression in Medicare: A retrospective claims database analysis

P. Greenberg, J. Sheehan, P. Lefebvre, 2019, PloS one.

US Integrated Delivery Networks Perspective on Economic Burden of Patients with Treatment-Resistant Depression: A Retrospective Matched-Cohort Study

P. Greenberg, J. Sheehan, P. Lefebvre, 2019, PharmacoEconomics - Open.

Medicaid spending burden among beneficiaries with treatment-resistant depression.

P. Greenberg, J. Sheehan, P. Lefebvre, 2019, Journal of comparative effectiveness research.

A Cross-Sectional Study of Patient Out-of-Pocket Costs for Antipsychotics Among Medicaid Beneficiaries with Schizophrenia.

P. Lefebvre, C. Benson, D. Pilon, 2023, Drugs - real world outcomes.

Projecting the Long-Term Economic Impact of Once-Monthly Paliperidone Palmitate Versus Oral Atypical Antipsychotics in Medicaid Patients with Schizophrenia

Edward Kim, P. Lefebvre, A. E. El Khoury, 2020, Journal of managed care & specialty pharmacy.

Patterns of relapse and associated cost burden in schizophrenia patients receiving atypical antipsychotics

E. Muser, J. Fastenau, M. Duh, 2013, Journal of medical economics.

Correction to: Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis

P. Mavros, P. Thompson-Leduc, P. Lefebvre, 2021, CNS Drugs.

Health Care Resource Utilization and Costs Associated with Transitioning to 3-month Paliperidone Palmitate Among US Veterans.

B. Shiner, Y. Young-Xu, P. Lefebvre, 2018, Clinical therapeutics.

Adherence, persistence, and inpatient utilization among adult schizophrenia patients using once-monthly versus twice-monthly long-acting atypical antipsychotics

Yongling Xiao, M. Alcusky, P. Thompson-Leduc, 2018, Journal of medical economics.

Baseline characteristics and treatment patterns of patients with schizophrenia initiated on once-every-three-months paliperidone palmitate in a real-world setting

P. Lefebvre, N. Tandon, K. Joshi, 2017, Current medical research and opinion.

Impact of Paliperidone Palmitate Versus Oral Atypical Antipsychotics on Health Care Resource Use and Costs in Veterans With Schizophrenia and Comorbid Substance Abuse.

B. Shiner, Y. Young-Xu, E. Muser, 2017, Clinical therapeutics.

Body mass index increase and weight gain among people living with HIV-1 initiated on single-tablet darunavir/cobicistat/emtricitabine/tenofovir alafenamide or bictegravir/emtricitabine/tenofovir alafenamide in the United States

P. Lefebvre, B. Bookhart, M. Lafeuille, 2021, Current medical research and opinion.

VTE Recurrence and Safety of Anticoagulants Among Patients with Cancer Treated for Venous Thromboembolism

A. Khorana, J. Schein, K. McCrae, 2017 .

A. Khorana, J. Schein, K. McCrae, 2016 .

An answer to “anticoagulant treatment of cancer‐associated venous thromboembolism: Interpreting real‐world data with caution”

A. Khorana, W. Nelson, J. Schein, 2018, American journal of hematology.

Impact of switching to infliximab biosimilars on treatment patterns among US veterans receiving innovator infliximab

Y. Young-Xu, R. Melsheimer, P. Lefebvre, 2022, Current medical research and opinion.

Impact of renal function on ischemic stroke and major bleeding rates in nonvalvular atrial fibrillation patients treated with warfarin or rivaroxaban: a retrospective cohort study using real-world evidence

J. Schein, J. Berger, M. Weir, 2017, Current medical research and opinion.

Incremental direct and indirect costs of untreated vasomotor symptoms

P. Sarrel, M. Duh, D. Portman, 2015, Menopause.

Prevalence of Pre-existing Conditions Relevant for Adverse Events and Potential Drug–Drug Interactions Associated with Augmentation Therapies Among Patients with Treatment-Resistant Depression

L. Citrome, J. Sheehan, P. Lefebvre, 2021, Advances in Therapy.

Assessing barriers to access and equity for COVID-19 vaccination in the US

P. Lefebvre, J. LaMori, Marco Mesa-Frias, 2022, BMC Public Health.

Treatment patterns among patients with mantle cell lymphoma and comparison of healthcare resource utilization and costs among relapsed/refractory patients treated with ibrutinib or chemoimmunotherapy: A real-world retrospective study.

N. Ghosh, P. Lefebvre, M. Lafeuille, 2021, Clinical therapeutics.

Retrospective Study on the Association of Biomarkers With Real-world Outcomes of Omalizumab-treated Patients With Allergic Asthma.

P. Lefebvre, B. Ortiz, J. Lecocq, 2019, Clinical therapeutics.

Comparing Clinical and Economic Outcomes Associated with Early Initiation of Combination Therapy of an Alpha Blocker and Dutasteride or Finasteride in Men with Benign Prostatic Hyperplasia in the United States

Yongling Xiao, A. Swensen, M. Duh, 2016, Journal of managed care & specialty pharmacy.

Hospitalizations and Other Health Care Resource Utilization Among Patients with Deep Vein Thrombosis Treated with Rivaroxaban Versus Low-molecular-weight Heparin and Warfarin in the Outpatient Setting.

W. Olson, J. Schein, P. Lefebvre, 2016, Clinical therapeutics.

Rates of hospitalization among patients with deep vein thrombosis before and after the introduction of rivaroxaban

J. Hollander, W. Olson, G. Merli, 2015, Hospital practice.

Modification of bone mineral density, bone geometry and volumetric BMD in young women with obesity.

E. Renard, L. Humbert, S. Guillaume, 2021, Bone.

Meta-Analysis of the Efficacy and Safety of Bortezomib Retreatment in Patients with Multiple Myeloma (MM)

K. Knopf, M. Duh, R. Comenzo, 2012 .

Assessing the clinical benefits of erythropoietic agents using area under the hemoglobin change curve.

C. Piech, J. Fastenau, M. Duh, 2005, The oncologist.

Management of anaemia: a critical and systematic review of the cost effectiveness of erythropoiesis-stimulating agents.

P. Greenberg, M. Duh, L. White, 2008, PharmacoEconomics.

Effects of the two types of anorexia nervosa (binge eating/purging and restrictive) on bone metabolism in female patients

P. Courtet, E. Renard, M. Picot, 2018, Clinical endocrinology.

Impact of paliperidone palmitate versus oral atypical antipsychotics on healthcare outcomes in schizophrenia patients.

Yongling Xiao, E. Muser, J. Fastenau, 2015, Journal of comparative effectiveness research.

Current Practice Patterns and Patient Persistence on Anticoagulant Treatments for Cancer-Associated Thrombosis

A. Khorana, W. Nelson, J. Schein, 2015 .

An Evaluation of Treatment Patterns and Outcomes in Elderly Patients Newly Diagnosed With Acute Myeloid Leukemia: A Retrospective Analysis of Electronic Medical Records From US Community Oncology Practices.

A. Chawla, B. Dezube, M. Duh, 2016, Clinical lymphoma, myeloma & leukemia.

The Rate of Venous Thromboembolism in Cancer Patients Varies By Khorana Risk Category

A. Khorana, G. Lyman, K. McCrae, 2018, Blood.

Evidence of a link between resting energy expenditure and bone remodelling, glucose homeostasis and adipokine variations in adolescent girls with anorexia nervosa

P. Courtet, E. Renard, J. Bringer, 2015, Osteoporosis International.

Venous thromboembolism recurrence among one-and-done direct oral anticoagulant users: a retrospective longitudinal study

M. Alberts, P. Lefebvre, B. Bookhart, 2023, International Journal of Clinical Pharmacy.

Venous Thromboembolism Recurrence Among Patients Who Abandon Oral Anticoagulant Therapy in the USA: A Retrospective Longitudinal Study

M. Alberts, P. Lefebvre, B. Bookhart, 2023, Advances in Therapy.

Adherence, Healthcare Resource Utilization, and Costs in Medicaid Beneficiaries with Schizophrenia Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone Palmitate

A. Khoury, P. Lefebvre, N. Tandon, 2018, PharmacoEconomics - Open.

Medication adherence among patients with advanced prostate cancer using oral therapies.

P. Lefebvre, J. LaMori, D. Pilon, 2021, Future oncology.

Respiratory Syncytial Virus–Related Complications and Healthcare Costs Among a Medicare-Insured Population in the United States

G. Krishnarajah, P. Lefebvre, Jessica K. DeMartino, 2023, Open forum infectious diseases.

Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA

S. Feldman, T. Fitzgerald, P. Lefebvre, 2023, Dermatology and Therapy.

Oral contraceptives partially protect from bone loss in young women with anorexia nervosa.

P. Courtet, E. Renard, M. Picot, 2019, Fertility and sterility.

Use of Antipsychotic Drugs in Patients with Alzheimer’s Disease Treated with Rivastigmine versus Donepezil

D. Scharre, F. Vekeman, M. Duh, 2010, Drugs & aging.

A specific association between laxative misuse and suicidal behaviours in patients with anorexia nervosa and bulimia nervosa

P. Courtet, E. Renard, S. Guillaume, 2021, Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity.

Treatment patterns and Medicaid spending in comorbid schizophrenia populations: once-monthly paliperidone palmitate versus oral atypical antipsychotics

P. Lefebvre, K. Joshi, D. Pilon, 2018, Current medical research and opinion.

Economic burden of attention-deficit/hyperactivity disorder among adults in the United States: a societal perspective.

L. Adler, P. Lefebvre, A. Childress, 2021, Journal of managed care & specialty pharmacy.

Short-term rehospitalizations in young adults with schizophrenia treated with once-monthly paliperidone palmitate or oral atypical antipsychotics: a retrospective analysis

A. Manceur, P. Lefebvre, A. E. El Khoury, 2018, Current medical research and opinion.

Comparison of rehospitalization rates and associated costs among patients with schizophrenia receiving paliperidone palmitate or oral antipsychotics.

E. Muser, M. Duh, P. Lefebvre, 2015, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Adherence to Rivaroxaban Compared with Other Oral Anticoagulant Agents Among Patients with Nonvalvular Atrial Fibrillation.

C. McHorney, E. Peterson, J. Schein, 2017, Journal of managed care & specialty pharmacy.

Burden of illness of patients with allergic asthma versus non-allergic asthma

P. Lefebvre, Jie Zhang, M. Lafeuille, 2013, The Journal of asthma : official journal of the Association for the Care of Asthma.

Weight Change and Predictors of Weight Change Among Patients Initiated on Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide or Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Real-World Retrospective Study

P. Lefebvre, M. Lafeuille, Aurélie Côté-Sergent, 2021, Journal of health economics and outcomes research.

An assessment of weight change associated with the initiation of a protease or integrase strand transfer inhibitor in patients with human immunodeficiency virus

P. Lefebvre, H. Hardy, M. Lafeuille, 2020, Current medical research and opinion.

Hospital length of stay: is rivaroxaban associated with shorter inpatient stay compared to warfarin among patients with non-valvular atrial fibrillation?

W. Olson, W. Nelson, J. Schein, 2014, Current medical research and opinion.

Benefits associated with an early hemoglobin response to epoetin alfa therapy in the treatment of chemotherapy-related anemia.

M. Duh, P. Lefebvre, S. Campos, 2005, Journal of the National Comprehensive Cancer Network : JNCCN.

Specific effects of anorexia nervosa and obesity on bone mineral density and bone turnover in young women.

P. Courtet, E. Renard, S. Guillaume, 2019, The Journal of clinical endocrinology and metabolism.

Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: a managed care perspective.

C. Piech, R. Bailey, F. Vekeman, 2009, Journal of managed care pharmacy : JMCP.

Epidemiology and patient journey of Rett syndrome in the United States: a real-world evidence study

P. Lefebvre, W. Cheng, M. Mahendran, 2023, BMC Neurology.

Selenium deficiency is associated with disease severity, disrupted reward processing, and increased suicide risk in patients with Anorexia Nervosa

P. Courtet, E. Renard, S. Guillaume, 2022, Psychoneuroendocrinology.

Burden of systemic glucocorticoid-related complications in severe asthma

Anand A. Dalal, H. Ortega, F. Albers, 2017, Current medical research and opinion.

Dose conversion and cost effectiveness of erythropoietic therapies in chemotherapy-related anemia: a Canadian application

P. Cremieux, F. Vekeman, P. Lefebvre, 2006, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Body composition changes in the first month after sleeve gastrectomy based on gender and anatomic site.

D. Nocca, D. Mariano-Goulart, L. Maïmoun, 2017, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

Healthcare costs of stroke and major bleeding in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants

E. Peterson, J. Schein, C. Coleman, 2019, Journal of medical economics.

Real-world adherence and economic outcomes associated with paliperidone palmitate versus oral atypical antipsychotics in schizophrenia patients with substance-related disorders using Medicaid benefits.

Edward Kim, P. Lefebvre, N. Tandon, 2018, Journal of comparative effectiveness research.

Long-Term Benefits of Rapid Antiretroviral Therapy Initiation in Reducing Medical and Overall Health Care Costs Among Medicaid-Covered Patients with Human Immunodeficiency Virus

P. Lefebvre, C. Benson, N. Tandon, 2019, Journal of managed care & specialty pharmacy.

Epidemiologic Evaluation of Cardiovascular Risk in Patients Receiving Milnacipran, Venlafaxine, or Amitriptyline: Evidence from French Health Data

P. Zimetbaum, P. Mease, F. Vekeman, 2011, The Annals of pharmacotherapy.

Risk Factors, Health Care Resource Utilization, and Costs Associated with Nonadherence to Antiretrovirals in Medicaid-Insured Patients with HIV

P. Lefebvre, J. Pesa, N. Tandon, 2018, Journal of managed care & specialty pharmacy.

Real-World Comparison of First-Line Treatment Adherence Between Single-Agent Ibrutinib and Acalabrutinib in Patients with Chronic Lymphocytic Leukemia

Z. Qureshi, P. Lefebvre, R. Jacobs, 2023, Patient preference and adherence.

Time to next treatment in patients with chronic lymphocytic leukemia initiating first-line ibrutinib or acalabrutinib.

Z. Qureshi, P. Lefebvre, R. Jacobs, 2023, Future oncology.

Is clinician impression of depression symptom severity associated with incremental economic burden in privately insured US patients with treatment resistant depression?

J. Sheehan, P. Lefebvre, K. Joshi, 2019, Journal of affective disorders.

Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users

W. Olson, W. Nelson, J. Schein, 2015, Advances in Therapy.

Public health impact of Rotarix vaccination among commercially insured children in the United States.

G. Krishnarajah, M. Duh, P. Lefebvre, 2017, Vaccine.

Ischemic stroke and systemic embolism among patients with non-valvular atrial fibrillation who abandon oral anticoagulant therapy

M. Alberts, P. Lefebvre, B. Bookhart, 2023, Current medical research and opinion.

Unintended Consequences of Increased Out-of-Pocket Costs During Medicare Coverage Gap on Anticoagulant Discontinuation and Stroke.

P. Lefebvre, F. Laliberté, U. Desai, 2023, Advances in therapy.

Real-world time to discontinuation of first-line venetoclax + obinutuzumab in chronic lymphocytic leukemia/small lymphocytic lymphoma.

Shaun P. Forbes, K. Rogers, Z. Qureshi, 2023, Current medical research and opinion.

Economic burden of illness among patients with pulmonary arterial hypertension (PAH) associated with connective tissue disorders (CTD)

A. Manceur, H. Germack, P. Lefebvre, 2023, Pulmonary circulation.

Rapid Initiation of Antiretroviral Therapy Following Diagnosis of Human Immunodeficiency Virus Among Patients with Commercial Insurance Coverage

P. Lefebvre, C. Benson, N. Tandon, 2019, Journal of Managed Care & Specialty Pharmacy.

Economic Burden of Treatment-Resistant Depression in Privately Insured U.S. Patients with Physical Conditions

Craig E. Nelson, P. Lefebvre, K. Joshi, 2020, Journal of Managed Care & Specialty Pharmacy.

Dose-Conversion Ratio for Epoetin Alfa and Darbepoetin Alfa in Chemotherapy Patients with Anemia and Cancer

C. Piech, S. Mody, M. Duh, 2006 .

Prasugrel vs. clopidogrel in acute coronary syndrome patients treated with prasugrel

W. Olson, P. Lefebvre, F. Laliberté, 2014, Journal of clinical pharmacy and therapeutics.

Consideration of Potential Drug-Drug Interactions in Selection of FDA-Approved Drugs Indicated for Prostate Cancer.

Yongling Xiao, P. Lefebvre, D. Pilon, 2019, American Journal of Therapeutics.

Healthcare Resource Utilization and Costs in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer Receiving First-Line Treatment in the United States: An Insurance Claims-Based Descriptive Analysis

P. Lefebvre, M. Lafeuille, I. Ghelerter, 2023, PharmacoEconomics - Open.

Erratum to: Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users

W. Olson, W. Nelson, J. Schein, 2015, Advances in Therapy.

Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users

W. Olson, W. Nelson, J. Schein, 2015, Advances in Therapy.

Daily costs of hospitalization in non-valvular atrial fibrillation patients treated with anticoagulant therapy

S. Mody, J. Dasta, P. Lefebvre, 2015, Journal of medical economics.

Hospital Length of Stay of Nonvalvular Atrial Fibrillation Patients who Were Administered Rivaroxaban versus Warfarin with and without Pretreatment Parenteral Anticoagulants Therapies

W. Olson, W. Nelson, J. Schein, 2014, Hospital practice.

Original article Patterns of relapse and associated cost burden in schizophrenia patients receiving atypical antipsychotics

E. Muser, J. Fastenau, M. Duh, 2013 .

Treatment Patterns and Medicaid Spending in Comorbid Schizophrenia Populations: Once-Monthly Paliperidone Palmitate Vs Oral Atypical Antipsychotics

P. Lefebvre, K. Joshi, D. Pilon, 2018 .

Characteristics of Real-World Commercially Insured Patients With Treatment-Resistant Depression Initiated on Esketamine Nasal Spray or Conventional Therapies in the United States.

P. Lefebvre, K. Joshi, D. Pilon, 2022, Clinical therapeutics.

Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities.

T. S. Chee, D. S. Kim, S. H. Lee, 2022, European journal of preventive cardiology.

Clinical predictors of survival in men with castration‐resistant prostate cancer

P. Kantoff, H. Ahmed, M. Taplin, 2013, Cancer.

Healthcare resource utilization and costs associated with venous thromboembolism in cancer patients treated with anticoagulants

A. Khorana, J. Schein, K. McCrae, 2019, Journal of medical economics.

Rates of hospitalization among patients with deep vein thrombosis before and after the introduction of rivaroxaban

J. Hollander, W. Olson, G. Merli, 2015, Hospital practice.

M. Prins, Yongling Xiao, P. Prandoni, 2018 .

Association of Self-Monitoring of Blood Glucose Use on Glycated Hemoglobin and Weight in Newly Diagnosed, Insulin-Naïve Adult Patients with Type 2 Diabetes

H. Parise, Lawrence D Garber, M. Duh, 2013, Journal of diabetes science and technology.

S. Brunton, P. Lefebvre, B. Bookhart, 2019, Current medical research and opinion.

Burden of schizophrenia on selected comorbidity costs

W. Olson, Michael Markowitz, J. Panish, 2014, Expert review of pharmacoeconomics & outcomes research.

Predictors of high healthcare resource utilization and liver disease progression among patients with chronic hepatitis C

P. Lefebvre, F. Laliberté, N. Tandon, 2015, Journal of medical economics.

An investigation into the durability of glycemic control in patients with type II diabetes initiated on canagliflozin or sitagliptin: A real-world analysis of electronic medical records.

C. Wysham, M. Duh, M. Ingham, 2019, Journal of diabetes and its complications.

Importance of balancing follow-up time and impact of oral-anticoagulant users’ selection when evaluating medication adherence in atrial fibrillation patients treated with rivaroxaban and apixaban

E. Peterson, J. Schein, C. Coleman, 2017, Current medical research and opinion.

Erythropoietin therapy and left ventricular mass index in CKD and ESRD patients: a meta-analysis.

P. Parfrey, P. Lefebvre, M. Lauve, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Development and evaluation of a predictive algorithm for unsatisfactory response among patients with pulmonary arterial hypertension using health insurance claims data

Jimmy Royer, P. Lefebvre, S. Panjabi, 2022, Current medical research and opinion.

Burden Of Schizophrenia On Selected Comorbidities Costs

W. Olson, Michael Markowitz, J. Panish, 2013 .

Original article Patterns of relapse and associated cost burden in schizophrenia patients receiving atypical antipsychotics

E. Muser, J. Fastenau, M. Duh, 2013 .

Oral contraceptives partially protect from bone loss in young women with anorexia nervosa.

P. Courtet, E. Renard, M. Picot, 2019, Fertility and sterility.

Attainment of early, deep prostate-specific antigen response in metastatic castration-sensitive prostate cancer: A comparison of patients initiated on apalutamide or enzalutamide.

E. Muser, I. Khilfeh, P. Lefebvre, 2023, Urologic oncology.

The implications of previous history of anorexia nervosa in patients with current bulimia nervosa: Alterations in daily functioning, decision-making, and bone status.

P. Courtet, I. Jaussent, E. Renard, 2019, European eating disorders review : the journal of the Eating Disorders Association.